GlassScriptPhysician profile
Nicholas Lee Varakin
NPI 1013408210
$2,264.56
in general payments reported to CMS, 2019-2025
18 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,211 · 2022: $177 · 2023: $390 · 2024: $254 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,210.84 | 2021 | |
| Horizon Therapeutics Plc | $170.63 | 2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $147.83 | 2022-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $134.71 | 2023-2025 | Purified Cortrophin Gel |
| Amgen INC. | $108.29 | 2024-2025 | Krystexxa |
| Stryker Corporation | $99.65 | 2022-2023 | N/A |
| Organogenesis INC. | $97.96 | 2023-2025 | Via Matrix, Nushield, Novachor |
| Medtronic, INC. | $52.27 | 2023-2025 | Intellis Adaptivestim |
| Peerless Surgical INC. | $49.70 | 2023 | |
| Abbott Laboratories | $42.38 | 2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $29.32 | 2025 | |
| Treace Medical Concepts, INC. | $23.73 | 2025 | |
| Bioventus LLC | $20.48 | 2022 | |
| Paragon 28, INC. | $17.75 | 2022 | |
| Sebela Pharmaceuticals INC. | $16.05 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $14.76 | 2025 | Irrisept |
| Advanced Oxygen Therapy INC. | $14.26 | 2023 | Topical Oxygen Chamber For Extremities |
| Kowa Pharmaceuticals America, INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Varakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.